[Lignes directrices européennes pour l'assurance de la qualité dans le dépistage du cancer du col de l’utérus]
European Guidelines for Quality Assurance in Cervical Cancer Screening have been initiated in the Europe Against Cancer Programme. The first edition established the principles of organised population-based screening and stimulated numerous pilot projects. The second multidisciplinary edition was published in 2008 and comprises 250 pages divided into seven chapters prepared by 48 authors and contributors. Considerable attention has been devoted to organised, population-based programme policies which minimise adverse effects and maximise benefits of screening. It is hoped that this expanded guidelines edition will have a greater impact on countries in which screening programmes are still lacking and in which opportunistic screening has been preferred in the past. Other methodological aspects such as future prospects of human papillomavirus testing and vaccination in cervical cancer control have also been examined in the second edition; recommendations for integration of the latter technologies into European guidelines are currently under development in a related project supported by the European Union Health Programme. An overview of the fundamental points and principles that should support any quality-assured screening programme and key performance indicators are presented here in a summary document of the second guidelines edition in order to make these principles and standards known to a wider scientific community.
- Date de parution: mars 2008
- Editeur: Office des publications de l'Union européenne
[Journée mondiale contre les hépatites 2016]
Viral hepatitis is an inflammation of the liver caused by infection with a hepatitis virus.
ECDC coordinates the surveillance for hepatitis A, B and C to help EU countries assess the hepatitis disease burden, evaluate existing prevention and control strategies, and to define epidemiological trends or transmission patterns.
Is Europe ready to eliminate viral hepatitis? In order to eliminate viral hepatitis as a public health threat by 2030, Europe needs to focus on testing, treatment and surveillance. WHO global hepatitis target for 2030: A 90% reduction of new cases of chronic hepatitis.
- Date de parution: juillet 2016
- Editeur: European Centre for Disease prevention and Control (ECDC)
Faits sur l' endométriose].
Endometriosis is a disease in which tissue similar to the lining inside the uterus (called “the endometrium”), is found outside the uterus, where it induces a chronic inflammatory reaction that may result in scar tissue. It is primarily found on the pelvic peritoneum, ovaries, in the recto-vaginal septum, on the bladder, and bowel. In very rare cases it has been found on the diaphragm and in the lungs.
Endometriosis affects an estimated 1 in 10 women during their reproductive years (ie. usually between the ages of 15 to 49), which is approximately 176 million women in the world.
The symptoms of endometriosis include painful periods, painful ovulation, pain during or after sexual intercourse, abnormal bleeding, chronic pelvic pain, fatigue, and infertility, and can impact on general physical, mental, and social well being.
A general lack of awareness combined with a “normalisation” of symptoms results in a significant delay from when a woman first experiences symptoms until she eventually is diagnosed and treated.
- Date de parution: janvier 2012
- Editeur: World Endometriosis Society World Endometriosis Research Foundation